Farms.com Home   News

Evidence of Influenza A Infection and Risk of Transmission between Pigs and Farmworkers

Abstract: Evidence of influenza A infection and risk of transmission between pigs and farmworkers

Interspecies transmission of influenza A virus (IAV) between pigs and people represents a threat to both animal and public health. To better understand the risks of influenza transmission at the human-animal interface, we evaluated 1) the rate of IAV detection in swine farmworkers before and after work during two human influenza seasons, 2) assessed risk factors associated with IAV detection in farmworkers and 3) characterized the genetic sequences of IAV detected in both workers and pigs. Of 58 workers providing nasal passage samples during 8-week periods during the 2017/18 and 2018/19 influenza seasons, 33 (57%) tested positive by rRT-PCR at least once. Sixteen (27%) workers tested positive before work and 24 (41%) after work. At the sample level, 58 of 1,785 nasal swabs (3.2%) tested rRT-PCR positive, of which 20 of 898 (2.2%) were collected prior to work and 38 of 887 (4.3%) after work. Although farmworkers were more likely to test positive at the end of the working day (OR = 1.98, 95% CI 1.14-3.41), there were no influenza-like illness (ILI) symptoms, or other risk indicators, associated with IAV detection before or after reporting to work.

Click here to see more...

Trending Video

The Future of Swine Health: Advanced Diagnostics and Customized Vaccines

Video: The Future of Swine Health: Advanced Diagnostics and Customized Vaccines


In this interview, Jay Halliday of Vaxxinova US discusses how advanced diagnostic technologies are helping pork producers better identify, monitor, and respond to disease challenges within their herds.
Unlike traditional diagnostic methods, WGS enables the identification of multiple pathogens within a sample, supports surveillance of emerging variants, helps evaluate feedback programs, and improves isolate selection for autogenous vaccine development.
The conversation also explores the importance of customized vaccine solutions and the role of adjuvants such as Amplivac™ and Trigen™ in enhancing immune responses against key swine pathogens.